Amerikanische Gesellschaft für Hirudotherapie

Aeromonas hydrophila infections following clinical use of medicinal leeches: a review of published cases

Review published in Blood coagulation & fibrinolysis (1991)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewSicherheit & InfektionskontrolleLineaweaver WC et al. · Blood coagulation & fibrinolysis, 1991

Abstract

Ten Aeromonas hydrophila infections following postsurgical leech applications have been reported. These cases indicate that postsurgical wounds and damaged tissue can provide entry for either acute or delayed A. hydrophila infection. These infections can range from localized cellulitis to progressive myonecrosis and sepsis. These infections may occur with measurable frequency in groups of patients exposed to leeches. Based on this review, it is recommended that leeches be applied only to tissue with a reasonably certain arterial supply; that patients receive antibiotics against A. hydrophila prior to leech administration; and that consideration be given to prolonged antibiotic administration to patients discharged home with open wounds or questionably viable tissue after leech administration.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAeromonasAnimalsAnti-Bacterial AgentsBites and StingsGram-Negative Bacterial InfectionsHumansIncidenceLeechesPostoperative ComplicationsPremedication

Zusammenfassung

Aeromonas hydrophila infections following clinical use of medicinal leeches: a review of published cases.

Warum dies für die Hirudotherapie relevant ist

This review examined ten reported cases of Aeromonas hydrophila infections following postsurgical leech applications. The abstract describes infections ranging from localized cellulitis to progressive myonecrosis and sepsis, and recommends that leeches be applied only to tissue with a reasonably certain arterial supply, that patients receive antibiotics against A. hydrophila prior to leech administration, and that prolonged antibiotic administration be considered for patients discharged with open wounds or questionably viable tissue. This article is relevant to the American Society of Hirudotherapy as it addresses clinical safety considerations and infectious complications associated with medical leeching, directly informing risk management in postsurgical leech therapy.

Zitation

Aeromonas hydrophila infections following clinical use of medicinal leeches: a review of published cases

Lineaweaver WC et al. · Blood coagulation & fibrinolysis, 1991

DOIPubMed

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Safety ProtocolsAeromonas ManagementAeromonasHirudinDirect Thrombin InhibitorsAnticoagulation CompoundsHemostasisOtolaryngology

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.